SPONSOR
Olema Pharmaceuticals, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 1
Conditions studied: Breast CancerLocally Advanced Breast CancerMetastatic Breast CancerER Positive Breast CancerHER2 Negative Breast CarcinomaER-positive Breast CancerHER2-negative Breast Cancer
Olema Pharmaceuticals, Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer.
The trial portfolio spans Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Olema Pharmaceuticals, Inc.
How many clinical trials has Olema Pharmaceuticals, Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Olema Pharmaceuticals, Inc., of which 2 are actively recruiting participants. These trials cover conditions including Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Olema Pharmaceuticals, Inc. research focus on?
Olema Pharmaceuticals, Inc. clinical trials span Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, and additional conditions. The research pipeline includes Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Olema Pharmaceuticals, Inc. clinical trial?
To participate in a Olema Pharmaceuticals, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Olema Pharmaceuticals, Inc. trials with current recruitment status updated daily.
Clinical Trials by Olema Pharmaceuticals, Inc.
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast Cancer
NCT05508906 Phase 1
Recruiting
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
Metastatic Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology